SURVANTA
Google image searchProduct monograph
Active ingredient
beractant, 25 MG/ML
DIN: 02016109
Dosage form(s): SUSPENSION
Route(s) of administration: INTRATRACHEAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 30-JUN-2014
ATC:
- R07 — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD, )
- R07A — OTHER RESPIRATORY SYSTEM PRODUCTS (ATC, ATC/DDD)
- R07AA — Lung surfactants (ATC, ATC/DDD)
- R07AA02 — NATURAL PHOSPHOLIPIDS (ATC/DDD)
Pharmaceutical standard: MFR
